Barclays PLC Integra Lifesciences Holdings Corp Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Barclays PLC holds 25,167 shares of IART stock, worth $449,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,167

Previous 74,243 66.1%

Holding current value

$449,734

Previous $2.63 Million 72.13%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.14 - $34.72 $1.14 Million - $1.7 Million	-49,076 Reduced 66.1%	25,167 $733,000
Q1 2024 May 15, 2024	BUY	$33.4 - $45.2 $281,829 - $381,397	8,438 Added 12.82%	74,243 $2.63 Million
Q4 2023 Feb 15, 2024	BUY	$34.21 - $44.59 $832,226 - $1.08 Million	24,327 Added 58.65%	65,805 $2.87 Million
Q3 2023 Nov 07, 2023	SELL	$37.8 - $45.97 $505,385 - $614,618	-13,370 Reduced 24.38%	41,478 $1.58 Million
Q2 2023 Aug 03, 2023	BUY	$37.95 - $58.98 $779,910 - $1.21 Million	20,551 Added 59.92%	54,848 $2.26 Million
Q1 2023 May 04, 2023	SELL	$52.61 - $60.49 $3.89 Million - $4.47 Million	-73,948 Reduced 68.32%	34,297 $1.97 Million
Q4 2022 Feb 13, 2023	BUY	$42.17 - $58.6 $2 Million - $2.78 Million	47,418 Added 77.96%	108,245 $6.07 Million
Q3 2022 Nov 03, 2022	BUY	$42.28 - $57.17 $851,476 - $1.15 Million	20,139 Added 49.5%	60,827 $2.58 Million
Q2 2022 Aug 12, 2022	BUY	$53.86 - $66.52 $633,555 - $782,474	11,763 Added 40.67%	40,688 $2.2 Million
Q1 2022 May 16, 2022	BUY	$62.86 - $69.24 $568,254 - $625,929	9,040 Added 45.46%	28,925 $1.86 Million
Q4 2021 Feb 14, 2022	SELL	$62.47 - $73.25 $1.6 Million - $1.88 Million	-25,644 Reduced 56.32%	19,885 $1.33 Million
Q3 2021 Nov 09, 2021	SELL	$64.97 - $76.19 $632,093 - $741,252	-9,729 Reduced 17.61%	45,529 $3.12 Million
Q2 2021 Aug 13, 2021	BUY	$66.79 - $76.63 $1.11 Million - $1.28 Million	16,666 Added 43.19%	55,258 $3.77 Million
Q1 2021 May 13, 2021	SELL	$62.63 - $71.15 $515,758 - $585,920	-8,235 Reduced 17.59%	38,592 $2.67 Million
Q4 2020 Feb 11, 2021	SELL	$43.31 - $66.55 $599,843 - $921,717	-13,850 Reduced 22.83%	46,827 $3.04 Million
Q3 2020 Nov 12, 2020	SELL	$43.33 - $51.72 $415,794 - $496,305	-9,596 Reduced 13.66%	60,677 $2.87 Million
Q2 2020 Aug 12, 2020	BUY	$41.42 - $55.57 $734,045 - $984,811	17,722 Added 33.72%	70,273 $3.3 Million
Q1 2020 May 13, 2020	BUY	$36.67 - $61.04 $1.64 Million - $2.73 Million	44,796 Added 577.64%	52,551 $2.35 Million
Q4 2019 Feb 10, 2020	BUY	$55.73 - $62.49 $245,546 - $275,330	4,406 Added 131.56%	7,755 $451,000
Q3 2019 Nov 14, 2019	SELL	$53.29 - $64.59 $4.21 Million - $5.1 Million	-78,956 Reduced 95.93%	3,349 $201,000
Q2 2019 Aug 14, 2019	BUY	$46.45 - $55.85 $2.6 Million - $3.12 Million	55,896 Added 211.66%	82,305 $4.6 Million
Q1 2019 May 15, 2019	SELL	$42.97 - $57.33 $701,184 - $935,510	-16,318 Reduced 38.19%	26,409 $1.47 Million
Q4 2018 Feb 14, 2019	BUY	$42.62 - $64.51 $580,527 - $878,690	13,621 Added 46.8%	42,727 $1.93 Million
Q3 2018 Nov 14, 2018	SELL	$57.63 - $65.87 $3.7 Million - $4.23 Million	-64,147 Reduced 68.79%	29,106 $1.92 Million
Q2 2018 Aug 14, 2018	BUY	$54.05 - $67.23 $3.98 Million - $4.95 Million	73,684 Added 376.53%	93,253 $6.01 Million
Q1 2018 May 15, 2018	BUY	$46.55 - $57.38 $441,107 - $543,732	9,476 Added 93.89%	19,569 $1.08 Million
Q4 2017 Feb 14, 2018	SELL	$46.22 - $51.77 $494,461 - $553,835	-10,698 Reduced 51.45%	10,093 $483,000
Q3 2017 Nov 14, 2017	BUY	$47.8 - $53.63 $993,809 - $1.12 Million	20,791	20,791 $1.05 Million

Others Institutions Holding IART

# of Institutions

255

Shares Held

75.5M

Call Options Held

10.7K

Put Options Held

57.7K

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.49B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account